Contrasting Humana (HUM) & Anthem (ANTM)
Humana (NYSE: HUM) and Anthem (NYSE:ANTM) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings.
This table compares Humana and Anthem’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Humana pays an annual dividend of $1.60 per share and has a dividend yield of 0.6%. Anthem pays an annual dividend of $2.60 per share and has a dividend yield of 1.3%. Humana pays out 13.1% of its earnings in the form of a dividend. Anthem pays out 24.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Humana has raised its dividend for 2 consecutive years and Anthem has raised its dividend for 6 consecutive years. Anthem is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Earnings and Valuation
This table compares Humana and Anthem’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Humana||$53.87 billion||0.66||$2.66 billion||$12.25||20.15|
|Anthem||$88.03 billion||0.58||$5.75 billion||$10.56||18.28|
Anthem has higher revenue and earnings than Humana. Anthem is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Humana has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Anthem has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.
Insider & Institutional Ownership
99.1% of Humana shares are held by institutional investors. Comparatively, 89.5% of Anthem shares are held by institutional investors. 0.8% of Humana shares are held by insiders. Comparatively, 0.4% of Anthem shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a summary of recent ratings and target prices for Humana and Anthem, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Humana presently has a consensus price target of $242.67, suggesting a potential downside of 1.69%. Anthem has a consensus price target of $181.00, suggesting a potential downside of 6.21%. Given Humana’s stronger consensus rating and higher possible upside, research analysts plainly believe Humana is more favorable than Anthem.
Humana beats Anthem on 13 of the 17 factors compared between the two stocks.
Humana Inc. is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.
Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.